| Net Cash Provided by (Used in) Operating Activities |
$7,593 |
USD |
93% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
$6,000 |
USD |
-97% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Investing Activities |
$0 |
USD |
|
Q1 2024 |
Q1 2024 |
| Common Stock, Shares Authorized |
500,000,000 |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Common Stock, Shares, Issued |
118,096,844 |
shares |
82% |
Q3 2025 |
Q3 2025 |
| Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q3 2025 |
Q3 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$42,348 |
USD |
2493% |
Q2 2025 |
Q2 2025 |
| Interest Paid, Excluding Capitalized Interest, Operating Activities |
$0 |
USD |
|
Q1 2024 |
Q1 2024 |
| Deferred Tax Assets, Valuation Allowance |
$863,496 |
USD |
-8% |
Q3 2025 |
Q3 2025 |
| Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent |
0.21 |
pure |
0% |
Q1 2025 |
Q1 2025 |
| Deferred Tax Assets, Gross |
$1,167,025 |
USD |
|
Q2 2025 |
Q2 2025 |
| Depreciation |
$969 |
USD |
0% |
Q1 2025 |
Q1 2025 |
| Payments to Acquire Property, Plant, and Equipment |
$0 |
USD |
|
Q1 2024 |
Q1 2024 |
| Preferred Stock, Shares Issued |
0 |
shares |
-100% |
Q3 2025 |
Q3 2025 |
| Preferred Stock, Shares Authorized |
25,000,000 |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Additional Paid in Capital |
$3,845,040 |
USD |
85% |
Q3 2025 |
Q3 2025 |
| Preferred Stock, Shares Outstanding |
0 |
shares |
-100% |
Q3 2025 |
Q3 2025 |
| Deferred Tax Assets, Net of Valuation Allowance |
$0 |
USD |
|
Q3 2024 |
Q3 2024 |
| Interest Expense |
$240,501 |
USD |
44% |
Q3 2025 |
Q3 2025 |
| Preferred Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q3 2025 |
Q3 2025 |